Free Trial
NYSE:SQZ

SQZ Biotechnologies (SQZ) Stock Price, News & Analysis

SQZ Biotechnologies logo
$0.03 0.00 (0.00%)
As of 03/28/2025

About SQZ Biotechnologies Stock (NYSE:SQZ)

Key Stats

Today's Range
$0.03
$0.03
50-Day Range
$0.03
$0.07
52-Week Range
$0.25
$3.56
Volume
63 shs
Average Volume
455,220 shs
Market Capitalization
$825,748.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.

Remove Ads
Receive SQZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SQZ Biotechnologies and its competitors with MarketBeat's FREE daily newsletter.

SQZ Stock News Headlines

SQZ Biotechnologies Co Ordinary Shares
Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
SQZ Biotechnologies Company (SQZB)
Sqz Bio (SQZB) Earnings Dates & Reports
VC funding update: who raised money in March?
See More Headlines

SQZ Stock Analysis - Frequently Asked Questions

SQZ Biotechnologies' stock was trading at $0.03 at the beginning of the year. Since then, SQZ shares have decreased by 6.7% and is now trading at $0.0280.
View the best growth stocks for 2025 here
.

SQZ Biotechnologies (NYSE:SQZ) posted its earnings results on Wednesday, November, 10th. The company reported ($8.00) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($5.60) by $2.40. The company earned $4.76 million during the quarter, compared to analyst estimates of $11.64 million. SQZ Biotechnologies had a negative net margin of 369.96% and a negative trailing twelve-month return on equity of 119.83%.

SQZ Biotechnologies's stock reverse split before market open on Friday, July 7th 2023. The 1-10 reverse split was announced on Friday, July 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

SQZ Biotechnologies (SQZ) raised $75 million in an IPO on Friday, October 30th 2020. The company issued 4,400,000 shares at $16.00-$18.00 per share. BofA Securities and Stifel acted as the underwriters for the IPO and BTIG was co-manager.

Shares of SQZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SQZ Biotechnologies investors own include Minerva Neurosciences (NERV), Illumina (ILMN), NVIDIA (NVDA), Oramed Pharmaceuticals (ORMP), Absci (ABSI), Allogene Therapeutics (ALLO) and Beam Therapeutics (BEAM).

Company Calendar

Last Earnings
11/10/2021
Today
3/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Transportation
Current Symbol
NYSE:SQZ
Fax
N/A
Employees
1,620
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-79,460,000.00
Net Margins
-369.96%
Pretax Margin
-408.99%

Debt

Sales & Book Value

Annual Sales
$18.16 million
Price / Cash Flow
N/A
Book Value
$1.94 per share
Price / Book
0.01

Miscellaneous

Free Float
24,772,000
Market Cap
$825,748.00
Optionable
Not Optionable
Beta
2.34
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NYSE:SQZ) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners